1竞技官网

科学文献

我们与学术机构开展合作研究,以评估我们的管线产品。以下是发表的相关文献。

年:

Matching-Adjusted Indirect Treatment Comparison to Assess the Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 Versus Belantamab Mafodotin in DREAMM-2, Selinexor-Dexamethasone in STORM Part 2, and Melphalan Flufenamide-Dexamethasone in HORIZON for the Treatment of Patients With Triple-Class Exposed Relapsed or Refractory Multiple Myeloma

Weisel K, Krishnan A, Schecter JM, Vogel M, Jackson CC, […]

Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma

D Hoda, R Richards, EA.Faber, A Deol, D Porter, BD. Hun […]

Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, IncludingTriple-Class Exposure in the United States

S Jagannath, N Joseph, J He, C Crivera, AZ Fu, A Garret […]

LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

Mateos MV, Weisel K, De Stefano V, Goldschmidt H, Delfo […]

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

AD Cohen, S Parekh, BD Santomasso, JG Pérez-Larraya, N […]

您即将离开我们的网站

本网站使用Cookies来改善您的整体体验,让您下次访问网站时更加轻松快捷,为您带来更好的服务。具体内容请参阅 隐私政策 Cookie政策